NOVEL LACTOBACILLUS HELVETICUS UA881 STRAIN AND PROBIOTIC COMPOSITION FOR IMPROVING INTESTINAL PERMEABILITY AND METABOLIC DISORDERS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 10, 2024
app pub date -
Apr 4, 2024
filing date -
Apr 7, 2023
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present disclosure provides a novel Lactobacillus helveticus UA881 strain and/or its probiotic composition, as well as their uses for improving intestinal permeability and metabolic disorders. These include lowering levels of triacylglyceride and cholesterol levels, improving leaky gut and metabolism disorders, degrading uric acid and purine nucleosides, relieving gout arthritis, activating antioxidant systems, and generating micro-nutrients. The novel Lactobacillus helveticus UA881 strain and/or its metabolites can be used to prepare medicaments, food products, health food, and external products for these purposes. The invention includes the Lactobacillus helveticus UA881 strain, deposited at the National Institute of Technology and Evaluation (NITE) under accession number NITE BP-03802.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully